Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood

BMC Pediatrics

Volumn 11, Issue , 2011, Pages

  Laporte, Sylvie ^a   Couto Silva, Ana Claudia ^b   Trabado, Séverine ^c   Lemaire, Pierre ^d   Brailly Tabard, Sylvie ^c   Espérou, Hélène ^e   Michon, Jean ^f   Baruchel, André ^g   Fischer, Alain ^a   Trivin, Christine ^h   Brauner, Raja ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b University of the State of Bahia   (Brazil)

^c BICÊTRE HOSPITAL   (France)

^d LABORATOIRE G SCOP   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f INSTITUT CURIE   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; MELPHALAN; METHOTREXATE; MUELLERIAN INHIBITING FACTOR; VINCRISTINE; BIOLOGICAL MARKER; INHIBIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADOLESCENT DEVELOPMENT; ADULT; APLASTIC ANEMIA; ARTICLE; CHILDHOOD DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE BLOOD LEVEL; HUMAN; LEYDIG CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; OVARY FUNCTION; OVARY INSUFFICIENCY; PUBERTY; SIDE EFFECT; TESTIS DISEASE; TESTIS FUNCTION; WHOLE BODY RADIATION; BLOOD; COMPARATIVE STUDY; EVALUATION; GONADAL DISEASE; IMMUNOSUPPRESSIVE TREATMENT; OVARY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TESTIS;

ADOLESCENT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL DISORDERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INHIBINS; LUTEINIZING HORMONE; MALE; OVARY; RETROSPECTIVE STUDIES; TESTIS; TRANSPLANTATION CONDITIONING;

EID: 79951956766     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-11-20     Document Type: Article

References (27)

1. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001, 358(9278):271-276. 10.1016/S0140-6736(01)05482-4, 11498213.
2. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996, 87(7):3045-3052.
3. Andersson AM, Petersen JH, Jorgensen N, Jensen TK, Skakkebaek NE. Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab 2004, 89(6):2873-2879. 10.1210/jc.2003-032148, 15181071.
4. Jensen TK, Andersson AM, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997, 82(12):4059-4063. 10.1210/jc.82.12.4059, 9398713.
5. Pierik FH, Vreeburg JT, Stijnen T, De Jong FH, Weber RF. Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab 1998, 83(9):3110-3114. 10.1210/jc.83.9.3110, 9745412.
6. van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004, 11(6 Pt 1):601-606. 10.1097/01.GME.0000123642.76105.6E, 15545787.
7. Burr IM, Sizonenko PC, Kaplan SL, Grumbach MM. Hormonal changes in puberty. I. Correlation of serum luteinizing hormone and follicle stimulating hormone with stages of puberty, testicular size, and bone age in normal boys. Pediatr Res 1970, 4(1):25-35. 10.1203/00006450-197001000-00003, 5416996.
8. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970, 45:13-23. 10.1136/adc.45.239.13, 2020414, 5440182.
9. Andersson AM, Juul A, Petersen JH, Muller J, Groome NP, Skakkebaek NE. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 1997, 82(12):3976-3981. 10.1210/jc.82.12.3976, 9398699.
10. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969, 44:291-303. 10.1136/adc.44.235.291, 2020314, 5785179.
11. Couto-Silva AC, Trivin C, Esperou H, Michon J, Baruchel A, Lemaire P, et al. Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplant 2006, 38(6):427-432. 10.1038/sj.bmt.1705455, 16878146.
12. Rey RA, Belville C, Nihoul-Fekete C, Michel-Calemard L, Forest MG, Lahlou N, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. J Clin Endocrinol Metab 1999, 84(2):627-631. 10.1210/jc.84.2.627, 10022428.
13. Witten IHFE. Data Mining. 2005, Elsevier, Second.
14. van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hahlen K, Dohle GR, van den Heuvel-Eibrink MM. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer 2009, 52(1):108-112. 10.1002/pbc.21780, 18819129.
15. Crofton PM, Thomson AB, Evans AE, Groome NP, Bath LE, Kelnar CJ, et al. Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer?. Clin Endocrinol (Oxf) 2003, 58(3):296-301. 10.1046/j.1365-2265.2003.01712.x, 12608934.
16. Cicognani A, Cacciari E, Pasini A, Burnelli R, De Iasio R, Pirazzoli P, et al. Low serum inhibin B levels as a marker of testicular damage after treatment for a childhood malignancy. Eur J Pediatr 2000, 159(1-2):103-107. 10.1007/s004310050021, 10653341.
17. Lahteenmaki PM, Toppari J, Ruokonen A, Laitinen P, Salmi TT. Low serum inhibin B concentrations in male survivors of childhood malignancy. Eur J Cancer 1999, 35(4):612-619. 10.1016/S0959-8049(98)00396-7, 10492636.
18. Thomson AB, Campbell AJ, Irvine DC, Anderson RA, Kelnar CJ, Wallace WH. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 2002, 360(9330):361-367. 10.1016/S0140-6736(02)09606-X, 12241775.
19. van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, van den Bos C, et al. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. Hum Reprod 2007, 22(12):3215-3222. 10.1093/humrep/dem313, 17981817.
20. Lahteenmaki PM, Arola M, Suominen J, Salmi TT, Andersson AM, Toppari J. Male reproductive health after childhood cancer. Acta Paediatr 2008, 97(7):935-942. 10.1111/j.1651-2227.2008.00784.x, 18430073.
21. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997, 130(2):210-216. 10.1016/S0022-3476(97)70345-7, 9042122.
22. Matsumoto M, Shinohara O, Ishiguro H, Shimizu T, Hattori K, Ichikawa M, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999, 80(5):452-454. 10.1136/adc.80.5.452, 1717918, 10208952.
23. Fong SL, Laven JSE, Hakvoort-Cammel FGAJ, Schipper I, Visser JA, Themmen APN, de Jong FH, van den Heuvel-Eibrink MM. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum Reprod 2009, 24(4):982-990. 10.1093/humrep/den487, 19153092.
24. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998, 22(10):989-994. 10.1038/sj.bmt.1701483, 9849696.
25. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003, 88(11):5307-5314. 10.1210/jc.2003-030352, 14602766.
26. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003, 18(11):2368-2374. 10.1093/humrep/deg473, 14585889.
27. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, de Jong FH, Themmen AP, Hakvoort-Cammel FG, et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 2007, 92(10):3869-3874. 10.1210/jc.2006-2374, 17726078.